Instil Bio TIL
NASDAQ TIL
$5.78 -0.16 (-2.61%)
As of: Oct 21, 2026 · 3:59 PM EDT

Instil Bio (TIL) Operating Leases (2022 - 2026)

Updated

Instil Bio's Operating Leases was $1.84 million in Q2 2026, compared with $6,000 a year earlier.

Analysis

Instil Bio (TIL) Operating Leases (2022 - 2026) Analysis & Trends

At the end of FY2024, Operating Leases at Instil Bio came in at $1.02 million, down 64.7% from FY2023.

  • In earlier years, Operating Leases was $2.88 million in FY2023 (-44.4%) and $5.17 million in FY2022.
  • The Q2 2026 figure marks the highest quarterly Operating Leases since Q2 2024.
  • Across the past five years, year-over-year decline in Operating Leases ran from 35.9% in Q1 2023 to 99.7% in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Instil Bio 38.86 Mn 15.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.84 Mn
Jun 30, 2025 6,000.00
Mar 31, 2025 48,000.00
Dec 31, 2024 1.02 Mn
Sep 30, 2024 1.41 Mn
Jun 30, 2024 2.02 Mn
Mar 31, 2024 2.45 Mn
Dec 31, 2023 2.88 Mn
Sep 30, 2023 3.29 Mn
Jun 30, 2023 3.70 Mn
Mar 31, 2023 4.18 Mn
Dec 31, 2022 5.17 Mn
Sep 30, 2022 5.63 Mn
Jun 30, 2022 6.02 Mn
Mar 31, 2022 6.53 Mn
API Access

Instil Bio Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=TIL&period=max&api_key=YOUR_API_KEY